Feverfew 125 mg Capsules
Natural health product licensed in Canada
- Licence holder
- Exzell Pharma Inc.
- NPN or DIN-HM
- 80004543
- Status
- Inactive licence
- Licence date
- 15 November 2007
- Revision date
- 15 August 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Eau purifiée, Gélatine, Cellulose - microcrystalline, Stéarate de magnésium, phosphate de dicalcium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 2 Capsule | Not specified |
Uses authorised in Canada
Helps reduce severity and frequency of migraine headaches & associated nausea and vomiting when taken as a prophylactic.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult healthcare practitioner if symptoms persist or worsen or prior to use if you are taking blood thinners.
- Effets indésirables connus
Hypersensitivity/allergy, sore mouth or mouth ulcers, and/or gastrointestinal discomfort are known to occur, in which case, discontinue use.
Source
Official Health Canada record, licence 80004543
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging